🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you, Canerector Foundation, for investing $1.8 million in life-changing research to transform care for people with Ehlers-Danlos Syndrome. Read more: stmichaelsfoundation.com/our-stories/ca… #ehlersdanlossyndrome #notrare #connectivetissue #chronicpain The Ehlers-Danlos Society

Exciting things about to come… RCT on e-shunt vs VP shunt for NPH! CereVasc Thanks to charles matouk of Yale Department of Neurosurgery for sharing his experience with the team! Vitor Mendes Pereira Dr. DiestroKE Tom Marotta

🎬 Getting ready for #LINNCParis 2025 Course directors are fine-tuning the last details, teams are in full swing — everything is coming together for an exciting start tomorrow. 📸 A few behind-the-scenes shots… energy and focus are in the air. #INR #Neuroradiology

A few comments from the #LINNCParis directors on this innovation: Jacques Moret describes the procedure as "tremendous" yet also very simple, Laurent Spelle calls it "absolutely extraordinary", and Vitor Mendes Pereira says it is "a crazy idea, but a great idea" LINNC online 🧠

✅ Day 2 comes to a close at LINNC Paris 2025 Another full day of high-level discussion, cutting-edge cases, and standout Innovation Choice sessions carefully selected by our Course Directors. We wrapped it all up with a great moment — a group photo with our 47 faculty members

Staff physicians Vitor Mendes Pereira in 🇫🇷 presenting and Dr. DiestroKE in 🇨🇦 performing two live cases for #LINNC2025 Nicole Cancelliere Tom Marotta LINNC online 🧠 See you again next year!

Did my first live cases as primary operator for #LINNC2025 LINNC online 🧠 yesterday Neurovascular Center @ St. Michael's Hospital 🇨🇦 with boss Vitor Mendes Pereira moderating in Paris 🇫🇷 ! What a rush! Would not have been possible without the support of Nicole Cancelliere Tom Marotta our fellows, nurses and techs onsite! 🚀

A big congratulations to our fantastic graduating fellow Dr Jerry Ku! Jerry will be starting his practice in North Vancouver this July! 🥳🥳🥳 Vitor Mendes Pereira Dr. DiestroKE Tom Marotta University of Toronto Neurosurgery

#STROKE #TATAM RCT results show that transvenous embolization is more effective than transarterial embolization in terms of angiographic results at 3-6 months, with comparable morbidity. #AHAJournals ahajrnls.org/3FPY76Y

Big thanks to the St. Joseph’s Hospital #Medicine team for hosting us at #GrandRounds! We shared our work in #remote #robotic #neurointervention, including a live #thrombectomy demo from SJHC to SMH OR using our robot #CRONOS and Mentice simulator! #NextFrontier #INR #Toronto

🚨 Study Approved in Canada! STRIDE trial is launching to study the eShunt System — an endovascular alternative to VP shunts for normal pressure hydrocephalus (NPH). 👥 Now enrolling potential candidates 📩 [email protected] RADIS lab Neurovascular Center @ St. Michael's Hospital St. Michael's Hospital Foundation

.CereVasc has received investigational testing authorisation (ITA) from Follow us Health Canada and PHAC for the STRIDE trial—a clinical study evaluating the company’s eShunt system as a treatment for normal-pressure hydrocephalus @GovCanHealth Vitor Mendes Pereira neuronewsinternational.com/cerevasc-gains…

Thrilled to add the NeuraSignal #Robotic #TCD to the RADIS Lab’s tech toolbox! 🧰🧠 Big thanks to CEO Robert Hamilton for sparking great ideas with the team. Next stop: pushing #neurovascular innovation even further! 🚀 #Robotics #Collaboration Vitor Mendes Pereira Nicole Cancelliere

Vitor Mendes Pereira speaking on his approach to the envascular approach to venous causes of pulsatile tinnitus. Dr. David Eisenman explains the two factors necessary for PT to happen. #SNIS2025 @SNISInfo ESMINT Society CV Section Felipe C. Albuquerque Michael Chen, MD Dr. DiestroKE Matthew Amans

Division chief Vitor Mendes Pereira talking about one of his favorite topics, pulsatile tinnitus at #SNIS2025 @SNISInfo ESMINT Society CV Section Felipe C. Albuquerque Michael Chen, MD Dr. DiestroKE Matthew Amans Andrew Ducruet Matt Fusco Dorothea Altschul MD FAHA FSVIN @cruzcerebri Niko Mouchtouris, MD Aliya Siddiqui

Vitor Mendes Pereira Neurovascular Center @ St. Michael's Hospital demonstrating outcomes of the aneurysms treated with the Corindus CorPath GRX. #SNIS2025 @SNISInfo ESMINT Society CV Section Felipe C. Albuquerque Michael Chen, MD Dr. DiestroKE Matthew Amans Andrew Ducruet Matt Fusco Dorothea Altschul MD FAHA FSVIN @cruzcerebri Niko Mouchtouris, MD

Six-month results from a 'world-first' study evaluating robot-assisted brain aneurysm treatments show a 94% technical success rate and an mRS 0-2 rate of 98.9% with the CorPath GRX system, according to Vitor Mendes Pereira's presentation at #SNIS2025 SNIS Info Siemens Healthineers

NeuroIR division head Vitor Mendes Pereira RADIS lab presenting on the long term outcomes of aneurysms treated with the 🤖 #SNIS2025 @SNISInfo ESMINT Society CV Section Felipe C. Albuquerque Michael Chen, MD Dr. DiestroKE Matthew Amans Andrew Ducruet Matt Fusco Dorothea Altschul MD FAHA FSVIN @cruzcerebri Niko Mouchtouris, MD

Vitor Mendes Pereira discussing pCONUS and eCLIPs. May be useful after residuals with intrasaccular devices. #SNIS2025 @SNISInfo ESMINT Society CV Section Felipe C. Albuquerque Michael Chen, MD Dr. DiestroKE Matthew Amans Andrew Ducruet Matt Fusco Dorothea Altschul MD FAHA FSVIN @cruzcerebri Niko Mouchtouris, MD

🚀 Great milestone in robotic neurointervention! Six-month data show 94% technical success and 98.9% mRS 0–2—demonstrating safety and effectiveness in aneurysm treatment with CorPath GRX. Grateful to all our collaborators pushing boundaries with me. The future is here—Stay tuned!